Loss of MED23 leads to poor prognosis in invasive breast cancer
Purpose of the study: The molecular mechanism of lymphovascular invasion (LVI) which determines the early metastatic phenotype in breast cancer is still not fully understood. Lead from the METABRIC study revealed that MED23 correlated with negative LVI status (p=0.00005). Hence MED23 expression was...
| Main Authors: | Aliyeva, T.A., Joseph, C., Provenzano, E., Russell, R., Caldas, C., Sonbul, S., Nolan, C., Green, A.R., Rakha, E.A, Ellis, IO., Mukherjee, A. |
|---|---|
| Format: | Conference or Workshop Item |
| Published: |
2017
|
| Online Access: | https://eprints.nottingham.ac.uk/44000/ |
Similar Items
Cell division cycle 25C (CDC25C) expression confers poor prognosis in invasive breast cancer
by: Ojiegbe, S., et al.
Published: (2017)
by: Ojiegbe, S., et al.
Published: (2017)
Elevated expression of STK3 mRNA and protein is associated
with poor outcome in invasive breast cancer
by: Ojiegbe, S., et al.
Published: (2017)
by: Ojiegbe, S., et al.
Published: (2017)
Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes
by: Joseph, Chitra, et al.
Published: (2018)
by: Joseph, Chitra, et al.
Published: (2018)
FOXP1 expression correlates with better prognosis in invasive breast cancer including the ER-positive luminal subtype
by: Joseph, C., et al.
Published: (2017)
by: Joseph, C., et al.
Published: (2017)
The significance of tumour microarchitectural features in breast cancer prognosis: a digital image analysis
by: Roxanis, I., et al.
Published: (2018)
by: Roxanis, I., et al.
Published: (2018)
Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis
by: Kurozumi, Sasagu, et al.
Published: (2018)
by: Kurozumi, Sasagu, et al.
Published: (2018)
The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes
by: El Ansari, Rokaya, et al.
Published: (2018)
by: El Ansari, Rokaya, et al.
Published: (2018)
Rho-GTPase activating protein 18: a biomarker associated with good prognosis in invasive breast cancer
by: Aleskandarany, Mohammed A., et al.
Published: (2017)
by: Aleskandarany, Mohammed A., et al.
Published: (2017)
The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours
by: El Ansari, Rokaya, et al.
Published: (2018)
by: El Ansari, Rokaya, et al.
Published: (2018)
Severe diabetic papillopathy mimicking non-ar... [Med J Malaysia. 2012] - PubMed - NCBI
by: Mallika, P.S, et al.
Published: (2012)
by: Mallika, P.S, et al.
Published: (2012)
Growth Hormone increases gonadotropin receptors in poor-prognosis patients
by: Regan, S., et al.
Published: (2012)
by: Regan, S., et al.
Published: (2012)
IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients
by: Ahmad, Narmeen, et al.
Published: (2018)
by: Ahmad, Narmeen, et al.
Published: (2018)
Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohort
by: Mukherjee, A., et al.
Published: (2018)
by: Mukherjee, A., et al.
Published: (2018)
Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections
by: Muftah, Abir A., et al.
Published: (2017)
by: Muftah, Abir A., et al.
Published: (2017)
Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion
by: Sonbul, Sultan N., et al.
Published: (2018)
by: Sonbul, Sultan N., et al.
Published: (2018)
Pericytes promote malignant ovarian cancer progression in mice and predict poor prognosis in serous ovarian cancer patients
by: Sinha, D., et al.
Published: (2016)
by: Sinha, D., et al.
Published: (2016)
Live birth rates are satisfactory following multiple IVF treatment cycles
in poor prognosis patients
by: Mustafa, Kamarul Bahyah, et al.
Published: (2017)
by: Mustafa, Kamarul Bahyah, et al.
Published: (2017)
Live birth rates are satisfactory following multiple IVF treatment cycles in poor prognosis patients
by: Mustafa, K., et al.
Published: (2017)
by: Mustafa, K., et al.
Published: (2017)
Single-centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosis
by: Keane, Kevin, et al.
Published: (2017)
by: Keane, Kevin, et al.
Published: (2017)
Subtractive hybridization identifies stem cell-associated genes in an acute myeloid leukemia with poor prognosis
by: Ngiow, Shin Foong, et al.
Published: (2016)
by: Ngiow, Shin Foong, et al.
Published: (2016)
UNIRAZAK MEd lahir pakar pendidikan
Published: (2011)
Published: (2011)
Chemokine (C-C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinoma
by: Sonbul, Sultan N., et al.
Published: (2017)
by: Sonbul, Sultan N., et al.
Published: (2017)
Growth hormone supplementation improves implantation and pregnancy productivity rates for poor-prognosis patients undertaking IVF
by: Yovich, John, et al.
Published: (2010)
by: Yovich, John, et al.
Published: (2010)
Manual MEdSI: inventori pemilihan pendidik Malaysia oleh Jawatankuasa Pembangunan Instrumen MEdSI IPTA
by: Othman, Joharry
Published: (2008)
by: Othman, Joharry
Published: (2008)
Thinking PubMed: an innovative system for mental health domain
by: Hadzic, Maja, et al.
Published: (2008)
by: Hadzic, Maja, et al.
Published: (2008)
Reach the top with UniRazak's MEd courses
Published: (2011)
Published: (2011)
Five new MEd courses at UniRazak
Published: (2010)
Published: (2010)
A Framework of an Intelligent Maintenance Prognosis Tool
by: Asmai, S. A., et al.
Published: (2010)
by: Asmai, S. A., et al.
Published: (2010)
DHEA supplementation confers no additional benefit to that of growth hormone on pregnancy and live birth rates in IVF patients categorized as poor prognosis
by: Keane, Kevin, et al.
Published: (2018)
by: Keane, Kevin, et al.
Published: (2018)
Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification
by: Aleskandarany, Mohammed A., et al.
Published: (2015)
by: Aleskandarany, Mohammed A., et al.
Published: (2015)
Total loss of MHC class I is an independent indicator of good prognosis in breast cancer
by: Madjd, Zahra, et al.
Published: (2005)
by: Madjd, Zahra, et al.
Published: (2005)
Validating and comparing stroke prognosis scales
by: Quinn, Terence J., et al.
Published: (2017)
by: Quinn, Terence J., et al.
Published: (2017)
Panduan Rasmi MEdSI (Malaysian Educators Selection Inventory)
by: Othman, Joharry
Published: (2009)
by: Othman, Joharry
Published: (2009)
Panduan rasmi MEdSI : Malaysian educators selection inventory
by: Borhan, Lihanna, et al.
Published: (2009)
by: Borhan, Lihanna, et al.
Published: (2009)
Service Innovation: Case Study On Spa And Med Beauty At The Saujana
by: Mohd Yusoff, Yusmani
Published: (2010)
by: Mohd Yusoff, Yusmani
Published: (2010)
Service Innovation: Case Study On Spa And Med
Beauty At The Saujana
by: Mohd Yusoff, Yusmani
Published: (2010)
by: Mohd Yusoff, Yusmani
Published: (2010)
The usefulness of med expert in
differentiating benign and malignant
breast lesions
by: Mazeda, Murad
Published: (2008)
by: Mazeda, Murad
Published: (2008)
An expert system for pneumococcal prognosis
by: Othman, Nurnadzirah, et al.
Published: (2018)
by: Othman, Nurnadzirah, et al.
Published: (2018)
Consensus clustering and fuzzy classification for breast cancer prognosis
by: Garibaldi, Jonathan M., et al.
Published: (2010)
by: Garibaldi, Jonathan M., et al.
Published: (2010)
Patient and caregiver perceptions of communication of prognosis in high grade glioma
by: Lobb, Elizabeth, et al.
Published: (2011)
by: Lobb, Elizabeth, et al.
Published: (2011)
Similar Items
-
Cell division cycle 25C (CDC25C) expression confers poor prognosis in invasive breast cancer
by: Ojiegbe, S., et al.
Published: (2017) -
Elevated expression of STK3 mRNA and protein is associated
with poor outcome in invasive breast cancer
by: Ojiegbe, S., et al.
Published: (2017) -
Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes
by: Joseph, Chitra, et al.
Published: (2018) -
FOXP1 expression correlates with better prognosis in invasive breast cancer including the ER-positive luminal subtype
by: Joseph, C., et al.
Published: (2017) -
The significance of tumour microarchitectural features in breast cancer prognosis: a digital image analysis
by: Roxanis, I., et al.
Published: (2018)